Pharmaceutical Regulatory Environment: Challenges and Opportunities in the Gulf Region
Description:
This book compares national and centralised procedure practices and key performance metrics, including current approval times, review practices and pharmacovigilance standards, in the seven Gulf States. Opportunities for an improved regulatory system are identified, which, if fully implemented, could have a significant impact on patients’ access to new medicines.The Persian Gulf represents the next growth market for the global biopharmaceutical industry but to date there has been limited information about the regulatory review processes employed in these countries. A thorough examination of the strategies currently being implemented by the Gulf States is considered critical to the future regulatory environment in this region.Pharmaceutical Regulatory Environment: Challenges & Opportunities in the Gulf Region is a must read for those interested in pharmaceutical regulation in the Gulf region.
Best prices to buy, sell, or rent ISBN 9783319175898
Frequently Asked Questions about Pharmaceutical Regulatory Environment: Challenges and Opportunities in the Gulf Region
You can buy the Pharmaceutical Regulatory Environment: Challenges and Opportunities in the Gulf Region book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $52.24 on Amazon and is available from 16 sellers at the moment.
If you’re interested in selling back the Pharmaceutical Regulatory Environment: Challenges and Opportunities in the Gulf Region book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Pharmaceutical Regulatory Environment: Challenges and Opportunities in the Gulf Region book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.